ISA-2011B is another newly discovered selective PIP5K1a inhibitor that specifically inhibits advanced PCa by reducing the activity of the PI3K/Akt, AR, and ERα pathways [119]. The gene discussed is AKT1; the disease is posterior cortical atrophy.